Hidehiro Hojo

760 total citations
54 papers, 464 citations indexed

About

Hidehiro Hojo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Hidehiro Hojo has authored 54 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 20 papers in Oncology and 19 papers in Surgery. Recurrent topics in Hidehiro Hojo's work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Advanced Radiotherapy Techniques (8 papers). Hidehiro Hojo is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Advanced Radiotherapy Techniques (8 papers). Hidehiro Hojo collaborates with scholars based in Japan, India and United States. Hidehiro Hojo's co-authors include Tetsuo Akimoto, Atsushi Motegi, Masaki Nakamura, Naoki Nakamura, Shun‐Ichiro Kageyama, Katsuya Tsuchihara, Kenji Hotta, Sadamoto Zenda, Masayuki Okumura and H. Tachibana and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Hidehiro Hojo

49 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidehiro Hojo Japan 13 252 163 161 99 82 54 464
Chuangzhen Chen China 14 234 0.9× 89 0.5× 163 1.0× 138 1.4× 86 1.0× 39 481
Gyu Sang Yoo South Korea 13 211 0.8× 203 1.2× 100 0.6× 88 0.9× 91 1.1× 56 541
L. Chinsoo Cho United States 7 257 1.0× 116 0.7× 101 0.6× 193 1.9× 75 0.9× 11 537
Ligang Xing China 13 284 1.1× 169 1.0× 60 0.4× 86 0.9× 81 1.0× 44 594
Emily S. Lebow United States 12 380 1.5× 378 2.3× 92 0.6× 50 0.5× 51 0.6× 33 586
Shuichi Kanamori Japan 15 322 1.3× 178 1.1× 212 1.3× 173 1.7× 92 1.1× 27 663
Preeti K. Parhar United States 10 227 0.9× 187 1.1× 47 0.3× 140 1.4× 171 2.1× 24 572
Heike Scheithauer Germany 13 113 0.4× 133 0.8× 69 0.4× 107 1.1× 130 1.6× 15 377
Tingyong Fan China 11 107 0.4× 112 0.7× 158 1.0× 91 0.9× 65 0.8× 34 365
Takuya Kaminuma Japan 12 224 0.9× 91 0.6× 63 0.4× 96 1.0× 22 0.3× 36 382

Countries citing papers authored by Hidehiro Hojo

Since Specialization
Citations

This map shows the geographic impact of Hidehiro Hojo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidehiro Hojo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidehiro Hojo more than expected).

Fields of papers citing papers by Hidehiro Hojo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidehiro Hojo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidehiro Hojo. The network helps show where Hidehiro Hojo may publish in the future.

Co-authorship network of co-authors of Hidehiro Hojo

This figure shows the co-authorship network connecting the top 25 collaborators of Hidehiro Hojo. A scholar is included among the top collaborators of Hidehiro Hojo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidehiro Hojo. Hidehiro Hojo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saeki, Koichi, Masaki Nakamura, Hidehiro Hojo, et al.. (2024). Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of Administration. Cancer Immunology Research. 13(3). 353–364. 4 indexed citations
2.
3.
Kageyama, Shun‐Ichiro, Riu Yamashita, Kosuke Tanaka, et al.. (2023). Transposable elements potentiate radiotherapy-induced cellular immune reactions via RIG-I-mediated virus-sensing pathways. Communications Biology. 6(1). 818–818. 13 indexed citations
4.
Shibuki, Taro, Mitsuhito Sasaki, Hiroshi Imaoka, et al.. (2023). Palliative radiotherapy for tumor bleeding in patients with unresectable pancreatic cancer: a single-center retrospective study. Radiation Oncology. 18(1). 178–178. 1 indexed citations
5.
Nakamura, Masaki, Shun‐Ichiro Kageyama, Hidenari Hirata, et al.. (2023). Detection of Pretreatment Circulating Tumor DNA Predicts Recurrence after High-Dose Proton Beam Therapy for Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 116(5). 1085–1090. 3 indexed citations
6.
7.
Okumura, Masayuki, Shun‐Ichiro Kageyama, Riu Yamashita, et al.. (2022). Comprehensive screening for drugs that modify radiation-induced immune responses. British Journal of Cancer. 126(12). 1815–1823. 3 indexed citations
8.
9.
Kageyama, Shun‐Ichiro, Hidenari Hirata, Atsushi Motegi, et al.. (2021). Comparative analysis of the immune responses in cancer cells irradiated with X-ray, proton and carbon-ion beams. Biochemical and Biophysical Research Communications. 585. 55–60. 21 indexed citations
10.
Okumura, Masayuki, Hidehiro Hojo, Masaki Nakamura, et al.. (2021). Radiation pneumonitis after palliative radiotherapy in cancer patients with interstitial lung disease. Radiotherapy and Oncology. 161. 47–54. 8 indexed citations
11.
Hojo, Hidehiro, et al.. (2021). Clinical outcome after CyberKnife® radiosurgery re-irradiation for recurrent brain metastases. Cancer/Radiothérapie. 25(5). 457–462. 5 indexed citations
12.
Kageyama, Shun‐Ichiro, Syuzo Kaneko, Ryuji Hamamoto, et al.. (2020). Identification of the mutation signature of the cancer genome caused by irradiation. Radiotherapy and Oncology. 155. 10–16. 5 indexed citations
13.
Okumura, Masayuki, Atsushi Motegi, Sadamoto Zenda, et al.. (2020). Efficacy and safety of accelerated fractionated radiotherapy without elective nodal irradiation for T3N0 glottic cancer without vocal cord fixation. Head & Neck. 42(8). 1775–1782. 4 indexed citations
14.
Nakamura, Masaki, Shun‐Ichiro Kageyama, Hibiki Udagawa, et al.. (2020). Differences in failure patterns according to the EGFR mutation status after proton beam therapy for early stage non-small cell lung cancer. Radiotherapy and Oncology. 149. 14–17. 2 indexed citations
15.
Hojo, Hidehiro, et al.. (2020). Prospective evaluation of the setup errors and its impact on safety margin for cervical cancer pelvic conformal radiotherapy. Reports of Practical Oncology & Radiotherapy. 25(2). 260–265. 3 indexed citations
16.
Zhang, Haiqin, Hidehiro Hojo, Naoki Nakamura, et al.. (2020). Palliative Radiation Therapy for Macroscopic Hematuria Caused by Urothelial Cancer. SHILAP Revista de lepidopterología. 1(1). 201–207. 3 indexed citations
17.
Nakamura, Naoki, Sadamoto Zenda, Makoto Tahara, et al.. (2017). Proton beam therapy for olfactory neuroblastoma. Radiotherapy and Oncology. 122(3). 368–372. 30 indexed citations
18.
Motegi, Atsushi, Kenji Hotta, Ryosuke Kohno, et al.. (2016). Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced non-small cell lung cancer. Japanese Journal of Clinical Oncology. 46(11). 1008–1014. 7 indexed citations
19.
Hojo, Hidehiro, et al.. (2015). A new two-step accurate CT-MRI fusion technique for post-implant prostate cancer. Journal of Contemporary Brachytherapy. 2(2). 117–121. 11 indexed citations
20.
Karasawa, Kumiko, Takahisa Hirai, Hidehiro Hojo, et al.. (2012). Comparison of hypofractionated and conventionally fractionated whole-breast irradiation for early breast cancer patients: a single-institute study of 1,098 patients. Breast Cancer. 21(4). 402–408. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuangzhen Chen Breakdown of academic impact, for papers by Gyu Sang Yoo Breakdown of academic impact, for papers by L. Chinsoo Cho Breakdown of academic impact, for papers by Ligang Xing Breakdown of academic impact, for papers by Emily S. Lebow Breakdown of academic impact, for papers by Shuichi Kanamori Breakdown of academic impact, for papers by Preeti K. Parhar Breakdown of academic impact, for papers by Heike Scheithauer Breakdown of academic impact, for papers by Tingyong Fan Breakdown of academic impact, for papers by Takuya Kaminuma
Rankless by CCL
2026